by In2Pharma | Sep 29, 2023 | News
Belgium The Belgian “National Medicines Verification System” (NMVS) is linked to the “European Alert Management System” (EAMS) via a “National Alert Management System” (NAMS) since 1 July 2023. Since there is now the possibility of...
by In2Pharma | Feb 12, 2019 | News
Belgium In light of the Falsified Medicines Directive, that came into effect on 9th February 2019, FAMHP has issued practical guidelines for the handling of complications during the initial phase of the new verification system. FAMHP and BeMVO have worked out an...
by In2Pharma | Dec 6, 2017 | News
Luxembourg As from 9 February 2019, the Falsified Medicines Directive (FMD) will apply. Based on this, the Luxembourg National Medicines Verification Organisation (LMVO) will implement a Luxembourg verification system in cooperation with the Belgian National Medicines...
by In2Pharma | Sep 27, 2017 | News
Belgium Riziv/Inami, FAMHP and BeMVO published together a joint declaration concerning the implementation of the Falsified Medicines Directive (FMD) in Belgium. In this joint declaration, several arrangements have been laid down to optimize the cooperation between the...
by In2Pharma | Jun 21, 2017 | News
BeMVO Every Marketing Authorization Holder (MAH) that distributes medicinal products that fall within the Belgian scope of the Falsified Medicines Directive (FMD) by February 9th 2019 must register to and contract with the Belgian Medicines Verification Organisation...
